EuroHYP gets EU grant award for stroke research

UK-based Proteome Sciences this week reported that Euro-HYP-1, a consortium of leading academic, clinical and industrial European partners in which it is a member, has been awarded a near 11 million-euro ($14.5 million) grant under the European Union Framework 7 program for new ground breaking research on the treatment of stroke.

Cooling the brain within six hours of a stroke has been proven in pilot studies to be remarkably effective in saving patients and reducing brain damage. The Framework 7 grant will be used to fund an EU-wide multicenter Phase III clinical trial in 25 countries involving 60 participating universities to treat 1,500 volunteer stroke victims with mild hypothermia.

For this clinical trial, Proteome Sciences as a consortium member will be undertaking the biomarker analysis of patient samples in blood and using MS based assays that it has developed incorporating proprietary stroke biomarkers it has previously discovered and validated.